Rani Therapeutics Holdings, Inc. (RANI)
NASDAQ: RANI · Real-Time Price · USD
1.400
+0.100 (7.69%)
At close: Dec 20, 2024, 4:00 PM
1.420
+0.020 (1.42%)
After-hours: Dec 20, 2024, 6:35 PM EST
RANI Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | - | - | - | 2.72 | 0.46 | 0.98 |
| Revenue Growth (YoY) | - | - | - | 488.10% | -52.81% | - |
| Gross Profit | - | - | - | 2.72 | 0.46 | 0.98 |
| Selling, General & Admin | 24.31 | 26.48 | 26.84 | 27.83 | 4.96 | 3.47 |
| Research & Development | 27.48 | 39.62 | 36.61 | 26.48 | 12.04 | 24.58 |
| Operating Expenses | 51.79 | 66.1 | 63.45 | 54.32 | 17.01 | 28.04 |
| Operating Income | -51.79 | -66.1 | -63.45 | -51.6 | -16.54 | -27.07 |
| Interest Expense | -5.21 | -5.09 | -1.07 | -0.47 | -0.12 | -0.01 |
| Interest & Investment Income | 2.08 | 3.3 | 1.25 | 0.09 | 0.06 | 0.42 |
| Other Non Operating Income (Expenses) | - | - | - | -0.37 | -0.06 | 0.07 |
| EBT Excluding Unusual Items | -54.92 | -67.88 | -63.27 | -52.35 | -16.67 | -26.59 |
| Other Unusual Items | - | - | - | -0.7 | - | - |
| Pretax Income | -54.92 | -67.88 | -63.27 | -53.05 | -16.67 | -26.59 |
| Income Tax Expense | - | - | 0.07 | 0.04 | 0.04 | - |
| Earnings From Continuing Operations | -54.92 | -67.88 | -63.34 | -53.09 | -16.7 | -26.59 |
| Minority Interest in Earnings | 26.75 | 33.91 | 32.76 | 44.76 | 16.7 | - |
| Net Income | -28.17 | -33.97 | -30.59 | -8.33 | - | -26.59 |
| Net Income to Common | -28.17 | -33.97 | -30.59 | -8.33 | - | -26.59 |
| Shares Outstanding (Basic) | 27 | 26 | 24 | 20 | 47 | 47 |
| Shares Outstanding (Diluted) | 27 | 26 | 24 | 20 | 47 | 47 |
| Shares Change (YoY) | 5.97% | 7.09% | 21.93% | -58.34% | - | - |
| EPS (Basic) | -1.05 | -1.33 | -1.28 | -0.43 | - | -0.57 |
| EPS (Diluted) | -1.05 | -1.33 | -1.28 | -0.43 | - | -0.57 |
| Free Cash Flow | -39.72 | -52.47 | -48.13 | -32.75 | -16.16 | -27.85 |
| Free Cash Flow Per Share | -1.48 | -2.06 | -2.02 | -1.68 | -0.34 | -0.59 |
| Gross Margin | - | - | - | 100.00% | 100.00% | 100.00% |
| Operating Margin | - | - | - | -1899.12% | -3580.95% | -2764.56% |
| Profit Margin | - | - | - | -306.62% | - | -2715.73% |
| Free Cash Flow Margin | - | - | - | -1205.41% | -3497.84% | -2844.54% |
| EBITDA | -50.8 | -65.28 | -62.9 | -51.1 | -15.96 | -26.5 |
| D&A For EBITDA | 0.99 | 0.82 | 0.55 | 0.5 | 0.59 | 0.56 |
| EBIT | -51.79 | -66.1 | -63.45 | -51.6 | -16.54 | -27.07 |
Source: S&P Capital IQ. Standard template.
Financial Sources.